Paper72792
Complement dependen cytotoxic antibody activity against measles virus in multiple sclerosis.
Kratzsch V and 1 other. J Neurol, 1977. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Complement dependen cytotoxic antibody activity against measles virus in multiple sclerosis. Papers, record 72792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/72792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complement dependen cytotoxic antibody activity against measles virus in multiple sclerosis.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| Measles virus | Major topic |
| Multiple Sclerosis | Major topic |
| Complement System Proteins | |
| Cytotoxicity Tests, Immunologic | |
| Female | |
| Hemagglutination Inhibition Tests | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4163412 | Persistent infection of cells in culture by measles virus. I. Development and characteristics of HeLa sublines persistently infected with complete virus. | J Bacteriol | 1966 | https://conductscience.org/library/papers/4163412 | PubMed |
| 2 | 4589922 | Clinical data from 418 MS patients in relation to the diagnosis. First experiences with an optical mark reader documentation system. | Acta Neurol Scand | 1973 | https://conductscience.org/library/papers/4589922 | PubMed |
| 3 | 13755335 | On the evaluation of disability in multiple sclerosis. | Neurology | 1961 | https://conductscience.org/library/papers/13755335 | PubMed |
| 4 | 803529 | Antibody-mediated cytotoxicity after measles virus infection. | J Immunol | 1975 | https://conductscience.org/library/papers/803529 | PubMed |
| 5 | 4614049 | Cytotoxic antibody activity in measles and subacute sclerosing panencephalitis (SSPE) infection. | Med Microbiol Immunol | 1974 | https://conductscience.org/library/papers/4614049 | PubMed |
| 6 | 4131598 | Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum. | Arch Neurol | 1974 | https://conductscience.org/library/papers/4131598 | PubMed |
| 7 | 4118046 | Appearance and persistence of antibodies against different virus components after regular measles infections. | Infect Immun | 1972 | https://conductscience.org/library/papers/4118046 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 500802 | Cytotoxic antibody to cells infected with measles virus in serum and cerebrospinal fluid of multiple sclerosis and control patients. | J Clin Microbiol | 1979 | https://conductscience.org/library/papers/500802 | PubMed |
| 72793 | Serological response of multiple sclerosis patients and controls to 6/94-parainfluenza virus. | J Neurol | 1977 | https://conductscience.org/library/papers/72793 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/72792
GET https://conductscience.org/api/papers/v1/72792/authors